CVE-2019-10981

Description

In Vijeo Citect 7.30 and 7.40, and CitectSCADA 7.30 and 7.40, a vulnerability has been identified that may allow an authenticated local user access to Citect user credentials.

Category

7.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.15%
Vendor Advisory aveva.com
Affected: AVEVA AVEVA Vijeo Citect and CitectSCADA
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSA-19-150-01 mitigation third party advisory us government resource
https://sw.aveva.com/hubfs/assets-2018/pdf/security-bulletin/SecurityAdvisory_LFSec136.pdf patch vendor advisory
http://www.securityfocus.com/bid/108543 third party advisory vdb entry
https://security.cse.iitk.ac.in/responsible-disclosure third party advisory

Frequently Asked Questions

What is the severity of CVE-2019-10981?
CVE-2019-10981 has been scored as a high severity vulnerability.
How to fix CVE-2019-10981?
To fix CVE-2019-10981, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-10981 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2019-10981 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-10981?
CVE-2019-10981 affects AVEVA AVEVA Vijeo Citect and CitectSCADA.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.